- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05210244
Acute Beetroot Juice Supplementation in Amateur Climbers
January 26, 2022 updated by: Luis Berlanga, Universidad Francisco de Vitoria
Acute Effects of Beetroot Juice Supplementation Among Neuromuscular Performance in Amateur Climbers
Whereas beetroot juice (BJ) supplementation is shown to increase physical performance in endurance activities, its benefits in neuromuscular function and strength performance has been barely studied.
In this cross-over randomized placebo-controlled study, we investigated the effects of BJ acute supplementation in improving neuromuscular performance in amateur climbers
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Madrid
-
Pozuelo De Alarcón, Madrid, Spain, 28223
- Universidad Francisco de Vitoria
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- more than 18 years
- active climbing for, at least, last 6 months
Exclusion Criteria:
- smoking
- contraindications to BJ diet
- physical limitations, health problems, or musculoskeletal injuries
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: BJ supplementation
|
One serving of 70 mL of BJ (6.4 mmol of NO3) 3h before initiating the testing session
|
|
Placebo Comparator: PLA supplementation
|
One serving of 70 mL of juice (0.005 mmol of NO3) 3h before initiating the testing session
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in rate of force development (N/s) at 50, 100 and 200 ms; and at 95% of maximal force
Time Frame: 1 week
|
Using a force sensor
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in maximal jump height (cm)
Time Frame: 1 week
|
Maximal jump height using a contact platform
|
1 week
|
|
Changes in maximal isometric handgrip strength (kg)
Time Frame: 1 week
|
Using a dynamometer
|
1 week
|
|
Changes in nitrites and nitrates levels in saliva (μmol/L)
Time Frame: 1 week
|
Using specific kit ELISA analysis
|
1 week
|
|
Changes in maximal number of pull-ups
Time Frame: 1 week
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Luis Berlanga, Universidad Francisco de Vitoria
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2021
Primary Completion (Actual)
November 15, 2021
Study Completion (Actual)
November 30, 2021
Study Registration Dates
First Submitted
January 25, 2022
First Submitted That Met QC Criteria
January 26, 2022
First Posted (Actual)
January 27, 2022
Study Record Updates
Last Update Posted (Actual)
January 27, 2022
Last Update Submitted That Met QC Criteria
January 26, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- UFV2020-44
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dietary Supplement
-
University of British ColumbiaCompletedDietary Supplement: Ketone Supplement | Dietary Supplement: PlaceboCanada
-
Universidad Francisco de VitoriaUniversidad de Granada; Universidad Rey Juan Carlos; Camilo Jose Cela UniversityCompleted
-
Medical University of WarsawUnknown
-
University of North Carolina, Chapel HillEnvironmental Protection Agency (EPA)CompletedHealthy | Dietary SupplementUnited States
-
University of BolognaNot yet recruiting
-
Universidad Pontificia ComillasEastern Mediterranean University; Northumbria University; Universidad Francisco... and other collaboratorsCompletedDietary Supplement | Sports PerformanceTurkey
-
Universidad de MurciaUniversidad Francisco de VitoriaCompleted
-
Northumbria UniversityCompletedExercise | Dietary SupplementTurkey (Türkiye)
-
Universidad Francisco de VitoriaCompletedPlacebo | Dietary SupplementSpain
Clinical Trials on Beetroot Juice (BJ) acute supplementation
-
Universidad de MurciaUniversidad Francisco de VitoriaCompleted
-
Universidad Pontificia ComillasUniversidad Complutense de Madrid; University of SevilleCompletedDietary Supplements: Beetroot Juice Acute Supplementation | Dietary Supplement: Placebo Acute SupplementationSpain
-
Queen's UniversityCompletedHeart Failure, Systolic
-
Sulaimany Polytechnic universityCompletedNAFLD, Non-alcoholic Fatty Liver DiseaseIraq
-
Melike Nur EroğluCompletedSupplementation | Exercise PerformanceTurkey
-
University School of Physical Education, Krakow...University of BergenCompleted
-
Oxford Brookes UniversityNot yet recruitingHypertension | Type 2 Diabetes Mellitus | Autonomic Nervous System DiseasesUnited Kingdom
-
University of CoimbraRecruitingDiabete Mellitus | Small Vessel Cerebrovascular DiseasePortugal
-
Bangor UniversityCompleted